PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Molecular Oncology0 citationsOpen Access

Tumor mutational burden as a determinant of metastatic dissemination patterns

View Full Paper
ECEduardo CandealAMAndrea Moreno‐ManuelMSMiguel Salvadó‐Pertierra

Key Points

  • Higher tumor mutational burden in CNS and lung metastases correlates with better prognosis, suggesting its role in metastasis.
  • Analysis of 19827 metastatic samples from nine cancer types shows variability in mutational patterns by cancer type.
  • No robust patterns were identified when examining driver mutations across different metastatic locations overall.
  • Findings indicate tumor mutational burden can refine strategies for immunotherapy, especially in CNS and lung cancers.

Abstract

According to the seed and soil hypothesis, the organ specificity of metastasis is not a random process and depends on multiple tumor-intrinsic and microenvironmental factors. In this study, we characterized the mutational landscape of a large cohort of human metastatic samples to investigate whether mutational trends determine metastatic dissemination. Genomic data from nine cancer types (bladder, breast, colorectal, endometrial, melanoma, non-small cell lung cancer, ovarian, pancreatic, and prostate) including 19827 patients were obtained from a pan-cancer study. When restricting the analysis to driver mutations, no robust, recurrent mutational patterns associated with metastatic locations were identified across cancer types. However, when cancer types were analyzed separately, mutational trends associated with specific metastatic locations emerged. Considering the total tumor mutational burden (TMB), central nervous system (CNS)/brain and lung metastases harbored a higher TMB than other metastatic locations. Since higher TMB in CNS/brain metastases was also associated with improved prognosis, these findings may be pivotal in refining immunotherapy strategies. Indeed, this observation was confirmed in an independent dataset including patients treated with immunotherapy. In conclusion, our findings suggest that TMB may have greater influence on metastatic organotropism than driver mutational background.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Candeal et al. (2026) studied this question.

synapsesocial.com/papers/69a75b54c6e9836116a22791https://doi.org/10.1002/1878-0261.70200
Ask AI
Helpful
Bookmark
Share
View Full Paper